Male depression: a review of gender concerns and testosterone therapy
Abstract
Depression, which affects approximately 6 million men in the United States, is associated with a high risk of mortality from comorbid medical illnesses and from suicide. Evidence suggests that depresssion affects men differently than women, and that older men in particular may experience special influences, symptoms, and consequences. The causes of late life depression can be divided into psychological, social, and biological factors. Special considerations for this population include laboratory studies to identify possible secondary medical abnormalities that may either accompany or derive from the depressed mood, and pharmacologic treatments that have been shown to be more efficacious in aging men. Research involving depressed hypogonadal and eugonadal men suggests that depressed men may benefit from testosterone augmentation.
Read the paper
Related studies
- Induced osteoblast differentiation by amide derivatives of stilbene: The possible osteogenic agents
- On model selections for repeated measurement data in clinical studies
- Regulation of GLUT transporters by flavonoids in androgen-sensitive and -insensitive prostate cancer cells
- Region-specific microRNA signatures in the human epididymis
- Synthesis, biological evaluation and molecular docking of 4-Amino-2H-benzo[h]chromen-2-one (ABO) analogs containing the piperazine moiety
- In Vitro characterization of the endocrine disrupting effects of per- and poly-fluoroalkyl substances (PFASs) on the human androgen receptor
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.